Pharmaceuticals, Biotechnology and Life Sciences
First Oral Norovirus GII.4 Tablet Vaccine Used in Clinical Trial SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc., a clinical-stage biotechnology company…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/AXAcandidates?src=hash” target=”_blank”gt;#AXAcandidateslt;/agt;–Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address…
LINCOLN, Neb.–(BUSINESS WIRE)–For the fourth consecutive year, biopharmaceutical industry executives have selected Celerion as an industry leader in multiple categories…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced data highlights from six presentations showcasing technology advances in the company’s antibody-drug…
25+-Year Veteran of Large Pharma, Willem H. Scheele, M.D., to Progress Company’s Clinical Development Program for Sickle Cell Disease, Thalassemia,…
DUBLIN–(BUSINESS WIRE)–The “Chemotherapy Induced Neutropenia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Chemotherapy Induced…
DUBLIN–(BUSINESS WIRE)–The “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24KALV&src=ctag" target="_blank"gt;$KALVlt;/agt;–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the…
Interim safety data together with early signals of efficacy will be presented in oral presentation at The International Liver Congress™…
Veeva Vault CDMS to manage clinical data for phase 2 and phase 3 post-operative pain trials PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CDMS?src=hash"…